Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

GLAND PHARMA LTD.

NSE : GLANDBSE : 543245ISIN CODE : INE068V01023Industry : Pharmaceuticals & DrugsHouse : Private

BSE1975.504.75 (+0.24 %)

PREV CLOSE ( ) 1970.75

OPEN PRICE ( ) 1971.25

BID PRICE (QTY) 1974.10 (10)

OFFER PRICE (QTY) 1975.60 (5)

VOLUME 3680

TODAY'S LOW / HIGH ( )1947.85 1995.10

52 WK LOW / HIGH ( )1200 2220.95

NSE1974.303.4 (+0.17 %)

PREV CLOSE( ) 1970.90

OPEN PRICE ( ) 1987.20

BID PRICE (QTY) 1974.30 (1)

OFFER PRICE (QTY) 1975.70 (8)

VOLUME 136800

TODAY'S LOW / HIGH( ) 1948.00 2000.90

52 WK LOW / HIGH ( )1277.8 2220.95

Select year

(Rs.in Million)

Particulars

Mar 2024

Mar 2023

Mar 2022

Mar 2021

Mar 2020

Profit Before Tax

11325.42

10545.82

16185.52

13348.10

9928.66

Adjustment

2236.03

381.92

-282.66

173.03

321.48

Changes In working Capital

-531.99

-4179.41

-3930.08

-4357.59

-799.42

Cash Flow after changes in Working Capital

13029.46

6748.33

11972.78

9163.54

9450.72

Cash Flow from Operating Activities

9967.97

3639.68

7907.69

6049.29

7009.35

Cash Flow from Investing Activities

-17569.11

12081.88

-10026.21

-15240.00

-7660.78

Cash Flow from Financing Activities

-7994.16

149.19

348.98

12384.60

-68.71

Net Cash Inflow / Outflow

-15595.30

15870.75

-1769.54

3193.89

-720.14

Opening Cash & Cash Equivalents

19088.95

3188.20

4924.63

1694.97

2364.02

Cash & Cash Equivalent on Amalgamation / Take over / Merger

Cash & Cash Equivalent of Subsidiaries under liquidations

Translation adjustment on reserves / op cash balalces frgn subsidiaries

Effect of Foreign Exchange Fluctuations

77.23

30.00

33.11

35.77

51.09

Closing Cash & Cash Equivalent

3570.88

19088.95

3188.20

4924.63

1694.97